MONTREAL, July 31 /CNW Telbec/ - Noveko International Inc. (“the Company”) is pleased to announce the appointment, effective immediately, of Mr. Barry McDonald as Chief Technical Officer of the Company, in replacement of Mr. Konstantin Goranov.
Mr. McDonald, who has more than 35 years of experience in the healthcare industry, was already acting as consultant for the Company since November 2008. In that regard, he has been actively interacting with the U.S. Food and Drug Administration (FDA) regarding the Noveko(TM) surgical mask certification process. Mr. McDonald’s experience in dealing with regulatory authorities has also been particularly helpful over the last few months while the Company continues to deploy its product and market development efforts.
Throughout his career, Mr. McDonald has acted both as an operating executive and as a consultant to the healthcare industry. He more recently held the position of Interim President and Chief Executive Officer of TSO3 Inc., a medical device company based in Quebec, and still sits on their Board of Directors. Mr. McDonald was previously Executive Director for the U.S. consulting firm The Sage Group. Mr. McDonald holds a M.S. in microbiology and genetics and B.S. in biochemistry and participated in the inaugural MD/PhD combined academic program at the University of Kentucky Albert Chandler Medical School.
Profile
Noveko International Inc. offers innovative solutions worldwide in the environmental and medical fields. Through its subsidiaries, the Company specializes in the following business segments: the development, manufacturing and marketing of derivative products from its patented antimicrobial filtration technology, primarily air filters, surgical masks and respirators, along with other products with antimicrobial properties such as AZURO(TM) hand sanitizers - and the development, manufacturing and marketing of medical equipment, primarily portable real-time ultrasound scanners for use in human and veterinary medicine.
Certain statements set forth in this press release constitute forward-looking statements. In some cases, these statements are identified by the use of terms such as “may”, “could”, “might”, “intend”, “should”, “expect”, “project”, “plan”, “believe”, “estimate” or other comparable variants. These statements are based on the information available at the time they are written, on assumptions made by management and on the expectations of management, acting in good faith, regarding future events, including those relating to economic conditions, fluctuations in exchange rates and operating expenses, and the absence of unusual events entailing supplementary expenditures. Although management considers these assumptions and expectations reasonable based on the information available at the time they are written, they could prove inaccurate. Forward-looking statements are also subject, by their very nature, to known and unknown risks and uncertainties such as those related to the industry, acquisitions, labor relations, credit, key officers, supply and product liability. The actual results of Noveko International Inc. could differ materially from those indicated or underlying these forward-looking statements. The reader is therefore recommended not to unduly rely on these forward-looking statements. Forward-looking statements do not reflect the potential impact of special items, any business combination or any other transaction that may be announced or occur subsequent to the date hereof. The Company undertakes no obligation to update or revise the forward-looking statements to account for new events or new circumstances, except where provided for by applicable legislation.
For further information
Chantal Vennat, Director, Investor Relations and Corporate Communications, Noveko International Inc., (514) 875-0606 http://www.noveko.com
